Doctors should consider cost-effectiveness and risks in prescribing treatment regimens, the American College of Physicians said in its revised ethics manual.
Published in Brief:
|Senior Director, Biostatistics||
|Associate - Food and Drug||
Keller and Heckman LLP
|Senior Paralegal - Research & Development, and Medical||